With this in mind, we conducted a careful evaluation of the performance of the new IBMP ELISA IgA/IgM/IgG COVID-19 kit for the detection of anti-SARS-CoV-2 antibodies in sera from individuals with COVID-19. This evidence concerns the gene CD79A and COVID-19.